Eversheds Ireland plays key role in the takeover of Paladin Labs by Endo Health
Eversheds Ireland has played a key role in the takeover by Endo Health Solutions of Paladin Labs Europe for approximately £1.1bn.
In this transaction, the acquiring entity will be an Irish holding company. The deal is the first Irish inversion with no primary Irish target.
An inversion is a legal transaction whereby one corporation becomes a subsidiary of another headquartered in a foreign jurisdiction and as a result the original corporation becomes subject to the tax laws of the foreign jurisdiction instead.
News from Eversheds
News from The Lawyer
Briefings from Eversheds
European Commission proposes reforms to merger control regime; how will this affect the aviation sector?
The European Commission has produced a white paper setting out proposals to improve and extend European Union merger control.
The potential impact of Ebola is of interest to all corporations with a presence in Africa, and in particular to those with projects, assets and personnel in the countries affected.
Analysis from The Lawyer
A new breed of lawyer is smoothing the path for companies entering emerging or unstable jurisdictions
‘Exotic’ investors and opportunities for legal work beyond M&A feature in The Lawyer’s high-level roundtable debate on south-east Europe